Genetic products maker Affymetrix Inc’s (NASDAQ:AFFX) second-quarter fiscal 2011 loss per share of 5 cents was a shade above the Zacks Consensus Estimate of a loss of 4 cents, but below the year-ago loss per share of 8 cents. The California-based company’s losses trimmed 33% year over year to $3.7 million as lower costs more [...]